NIAID is seeking volunteers who are newly diagnosed with mild COVID-19 who live within 50 miles of Bethesda, Maryland

Help Hang COVID-19 Out to Dry Do you have mild COVID-19? Consider joining a clinical research study. The National Institutes of Health (NIH) is conducting a study for adults with COVID-19. This study is being done to see if an experimental drug, IL-7 (NT-I7), is safe and whether it will help treat COVID-19 by supporting the immune system. The study will also provide standard treatments for COVID-19 as medically indicated.  Participants who enroll in the study will: Have about 8 study visits Be in the study for 3 months Be assigned to receive either the study drug or placebo (looks like the study drug, but has no drug in it) Get 1 injection of study drug or placebo in the arm or buttock, and stay at the NIH hospital for 5-7 days Be compensated for their time For more information, call: 1-800-411-1222 Reference Study #20-I-0140 TTY: 1-866-411-1010 Se habla español For more information about the study, visit Drug Treatment Study of Individuals with Mild COVID-19.        National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107